New safety information for healthcare professionals
Ontozry (cenobamate): new requirements for liver function monitoring due to reports of severe liver injury
For the full text of the announcement click here.
For the text, as published on the website of the European Medicines Agency (EMA), please visit://www.ema.europa.eu/
